A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol

by Tomoko Iehara, Akihiro Yoneda, Atsushi Kikuta, Toshihiro Muraji, Kazuaki Tokiwa, Hideto Takahashi, Satoshi Teramukai, Tetsuya Takimoto, Shigeki Yagyu, Hajime Hosoi, Tatsuro Tajiri, the Japan Children’s Cancer Group Neuroblastoma Committee
Published 2020-05-01